0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rheumatoid Arthritis Stem Cell Therapy Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-37L13526
Home | Market Reports | Health| Health Conditions| Arthritis
Global Rheumatoid Arthritis Stem Cell Therapy Market Research Report 2023
BUY CHAPTERS

Global Rheumatoid Arthritis Stem Cell Therapy Market Research Report 2025

Code: QYRE-Auto-37L13526
Report
July 2025
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Rheumatoid Arthritis Stem Cell Therapy Market

The global market for Rheumatoid Arthritis Stem Cell Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Rheumatoid arthritis stem cell therapy has been demonstrated to induce profound healing activity, halt arthritic conditions, and in many cases, reverse and regenerate joint tissue. Today, bone marrow transplant, adipose or fat-derived stem cells, and allogeneic mesenchymal stem cells (human umbilical cord tissue) are used for rheumatoid arthritis stem cell therapy. As the rheumatoid arthritis worsens, the body initiates autoimmune response and attacks the cells. Rheumatoid arthritis stem cell therapy is growing in popularity across hospitals, ambulatory surgical centers, and specialty clinics, as it increases the healing of joints and further treats the entire system that causes the joint pain and inflammation.
North American market for Rheumatoid Arthritis Stem Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Rheumatoid Arthritis Stem Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Rheumatoid Arthritis Stem Cell Therapy in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Rheumatoid Arthritis Stem Cell Therapy include Mesoblast, Roslin Cells, Regeneus, ReNeuron Group, International Stem Cell Corporation, Takeda, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rheumatoid Arthritis Stem Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rheumatoid Arthritis Stem Cell Therapy.
The Rheumatoid Arthritis Stem Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rheumatoid Arthritis Stem Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rheumatoid Arthritis Stem Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Rheumatoid Arthritis Stem Cell Therapy Market Report

Report Metric Details
Report Name Rheumatoid Arthritis Stem Cell Therapy Market
Segment by Type
  • Allogeneic Mesenchymal Stem Cells
  • Bone Marrow Transplant
  • Adipose Tissue Stem Cells
Segment by Application
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Mesoblast, Roslin Cells, Regeneus, ReNeuron Group, International Stem Cell Corporation, Takeda
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Rheumatoid Arthritis Stem Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Rheumatoid Arthritis Stem Cell Therapy Market report?

Ans: The main players in the Rheumatoid Arthritis Stem Cell Therapy Market are Mesoblast, Roslin Cells, Regeneus, ReNeuron Group, International Stem Cell Corporation, Takeda

What are the Application segmentation covered in the Rheumatoid Arthritis Stem Cell Therapy Market report?

Ans: The Applications covered in the Rheumatoid Arthritis Stem Cell Therapy Market report are Hospitals, Ambulatory Surgical Centers, Specialty Clinics

What are the Type segmentation covered in the Rheumatoid Arthritis Stem Cell Therapy Market report?

Ans: The Types covered in the Rheumatoid Arthritis Stem Cell Therapy Market report are Allogeneic Mesenchymal Stem Cells, Bone Marrow Transplant, Adipose Tissue Stem Cells

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rheumatoid Arthritis Stem Cell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Allogeneic Mesenchymal Stem Cells
1.2.3 Bone Marrow Transplant
1.2.4 Adipose Tissue Stem Cells
1.3 Market by Application
1.3.1 Global Rheumatoid Arthritis Stem Cell Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Specialty Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rheumatoid Arthritis Stem Cell Therapy Market Perspective (2020-2031)
2.2 Global Rheumatoid Arthritis Stem Cell Therapy Growth Trends by Region
2.2.1 Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Rheumatoid Arthritis Stem Cell Therapy Historic Market Size by Region (2020-2025)
2.2.3 Rheumatoid Arthritis Stem Cell Therapy Forecasted Market Size by Region (2026-2031)
2.3 Rheumatoid Arthritis Stem Cell Therapy Market Dynamics
2.3.1 Rheumatoid Arthritis Stem Cell Therapy Industry Trends
2.3.2 Rheumatoid Arthritis Stem Cell Therapy Market Drivers
2.3.3 Rheumatoid Arthritis Stem Cell Therapy Market Challenges
2.3.4 Rheumatoid Arthritis Stem Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rheumatoid Arthritis Stem Cell Therapy Players by Revenue
3.1.1 Global Top Rheumatoid Arthritis Stem Cell Therapy Players by Revenue (2020-2025)
3.1.2 Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Rheumatoid Arthritis Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Rheumatoid Arthritis Stem Cell Therapy Revenue
3.4 Global Rheumatoid Arthritis Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Rheumatoid Arthritis Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rheumatoid Arthritis Stem Cell Therapy Revenue in 2024
3.5 Global Key Players of Rheumatoid Arthritis Stem Cell Therapy Head office and Area Served
3.6 Global Key Players of Rheumatoid Arthritis Stem Cell Therapy, Product and Application
3.7 Global Key Players of Rheumatoid Arthritis Stem Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Rheumatoid Arthritis Stem Cell Therapy Breakdown Data by Type
4.1 Global Rheumatoid Arthritis Stem Cell Therapy Historic Market Size by Type (2020-2025)
4.2 Global Rheumatoid Arthritis Stem Cell Therapy Forecasted Market Size by Type (2026-2031)
5 Rheumatoid Arthritis Stem Cell Therapy Breakdown Data by Application
5.1 Global Rheumatoid Arthritis Stem Cell Therapy Historic Market Size by Application (2020-2025)
5.2 Global Rheumatoid Arthritis Stem Cell Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Rheumatoid Arthritis Stem Cell Therapy Market Size (2020-2031)
6.2 North America Rheumatoid Arthritis Stem Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2020-2025)
6.4 North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rheumatoid Arthritis Stem Cell Therapy Market Size (2020-2031)
7.2 Europe Rheumatoid Arthritis Stem Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2020-2025)
7.4 Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Market Size (2020-2031)
8.2 Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rheumatoid Arthritis Stem Cell Therapy Market Size (2020-2031)
9.2 Latin America Rheumatoid Arthritis Stem Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2020-2025)
9.4 Latin America Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size (2020-2031)
10.2 Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Mesoblast
11.1.1 Mesoblast Company Details
11.1.2 Mesoblast Business Overview
11.1.3 Mesoblast Rheumatoid Arthritis Stem Cell Therapy Introduction
11.1.4 Mesoblast Revenue in Rheumatoid Arthritis Stem Cell Therapy Business (2020-2025)
11.1.5 Mesoblast Recent Development
11.2 Roslin Cells
11.2.1 Roslin Cells Company Details
11.2.2 Roslin Cells Business Overview
11.2.3 Roslin Cells Rheumatoid Arthritis Stem Cell Therapy Introduction
11.2.4 Roslin Cells Revenue in Rheumatoid Arthritis Stem Cell Therapy Business (2020-2025)
11.2.5 Roslin Cells Recent Development
11.3 Regeneus
11.3.1 Regeneus Company Details
11.3.2 Regeneus Business Overview
11.3.3 Regeneus Rheumatoid Arthritis Stem Cell Therapy Introduction
11.3.4 Regeneus Revenue in Rheumatoid Arthritis Stem Cell Therapy Business (2020-2025)
11.3.5 Regeneus Recent Development
11.4 ReNeuron Group
11.4.1 ReNeuron Group Company Details
11.4.2 ReNeuron Group Business Overview
11.4.3 ReNeuron Group Rheumatoid Arthritis Stem Cell Therapy Introduction
11.4.4 ReNeuron Group Revenue in Rheumatoid Arthritis Stem Cell Therapy Business (2020-2025)
11.4.5 ReNeuron Group Recent Development
11.5 International Stem Cell Corporation
11.5.1 International Stem Cell Corporation Company Details
11.5.2 International Stem Cell Corporation Business Overview
11.5.3 International Stem Cell Corporation Rheumatoid Arthritis Stem Cell Therapy Introduction
11.5.4 International Stem Cell Corporation Revenue in Rheumatoid Arthritis Stem Cell Therapy Business (2020-2025)
11.5.5 International Stem Cell Corporation Recent Development
11.6 Takeda
11.6.1 Takeda Company Details
11.6.2 Takeda Business Overview
11.6.3 Takeda Rheumatoid Arthritis Stem Cell Therapy Introduction
11.6.4 Takeda Revenue in Rheumatoid Arthritis Stem Cell Therapy Business (2020-2025)
11.6.5 Takeda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Rheumatoid Arthritis Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Allogeneic Mesenchymal Stem Cells
 Table 3. Key Players of Bone Marrow Transplant
 Table 4. Key Players of Adipose Tissue Stem Cells
 Table 5. Global Rheumatoid Arthritis Stem Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Rheumatoid Arthritis Stem Cell Therapy Market Share by Region (2020-2025)
 Table 9. Global Rheumatoid Arthritis Stem Cell Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Rheumatoid Arthritis Stem Cell Therapy Market Share by Region (2026-2031)
 Table 11. Rheumatoid Arthritis Stem Cell Therapy Market Trends
 Table 12. Rheumatoid Arthritis Stem Cell Therapy Market Drivers
 Table 13. Rheumatoid Arthritis Stem Cell Therapy Market Challenges
 Table 14. Rheumatoid Arthritis Stem Cell Therapy Market Restraints
 Table 15. Global Rheumatoid Arthritis Stem Cell Therapy Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Rheumatoid Arthritis Stem Cell Therapy Market Share by Players (2020-2025)
 Table 17. Global Top Rheumatoid Arthritis Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatoid Arthritis Stem Cell Therapy as of 2024)
 Table 18. Ranking of Global Top Rheumatoid Arthritis Stem Cell Therapy Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Rheumatoid Arthritis Stem Cell Therapy Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Rheumatoid Arthritis Stem Cell Therapy, Headquarters and Area Served
 Table 21. Global Key Players of Rheumatoid Arthritis Stem Cell Therapy, Product and Application
 Table 22. Global Key Players of Rheumatoid Arthritis Stem Cell Therapy, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share by Type (2020-2025)
 Table 26. Global Rheumatoid Arthritis Stem Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share by Type (2026-2031)
 Table 28. Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share by Application (2020-2025)
 Table 30. Global Rheumatoid Arthritis Stem Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Rheumatoid Arthritis Stem Cell Therapy Revenue Market Share by Application (2026-2031)
 Table 32. North America Rheumatoid Arthritis Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Rheumatoid Arthritis Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Rheumatoid Arthritis Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Mesoblast Company Details
 Table 48. Mesoblast Business Overview
 Table 49. Mesoblast Rheumatoid Arthritis Stem Cell Therapy Product
 Table 50. Mesoblast Revenue in Rheumatoid Arthritis Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 51. Mesoblast Recent Development
 Table 52. Roslin Cells Company Details
 Table 53. Roslin Cells Business Overview
 Table 54. Roslin Cells Rheumatoid Arthritis Stem Cell Therapy Product
 Table 55. Roslin Cells Revenue in Rheumatoid Arthritis Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 56. Roslin Cells Recent Development
 Table 57. Regeneus Company Details
 Table 58. Regeneus Business Overview
 Table 59. Regeneus Rheumatoid Arthritis Stem Cell Therapy Product
 Table 60. Regeneus Revenue in Rheumatoid Arthritis Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 61. Regeneus Recent Development
 Table 62. ReNeuron Group Company Details
 Table 63. ReNeuron Group Business Overview
 Table 64. ReNeuron Group Rheumatoid Arthritis Stem Cell Therapy Product
 Table 65. ReNeuron Group Revenue in Rheumatoid Arthritis Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 66. ReNeuron Group Recent Development
 Table 67. International Stem Cell Corporation Company Details
 Table 68. International Stem Cell Corporation Business Overview
 Table 69. International Stem Cell Corporation Rheumatoid Arthritis Stem Cell Therapy Product
 Table 70. International Stem Cell Corporation Revenue in Rheumatoid Arthritis Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 71. International Stem Cell Corporation Recent Development
 Table 72. Takeda Company Details
 Table 73. Takeda Business Overview
 Table 74. Takeda Rheumatoid Arthritis Stem Cell Therapy Product
 Table 75. Takeda Revenue in Rheumatoid Arthritis Stem Cell Therapy Business (2020-2025) & (US$ Million)
 Table 76. Takeda Recent Development
 Table 77. Research Programs/Design for This Report
 Table 78. Key Data Information from Secondary Sources
 Table 79. Key Data Information from Primary Sources
 Table 80. Authors List of This Report


List of Figures
 Figure 1. Rheumatoid Arthritis Stem Cell Therapy Picture
 Figure 2. Global Rheumatoid Arthritis Stem Cell Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Rheumatoid Arthritis Stem Cell Therapy Market Share by Type: 2024 VS 2031
 Figure 4. Allogeneic Mesenchymal Stem Cells Features
 Figure 5. Bone Marrow Transplant Features
 Figure 6. Adipose Tissue Stem Cells Features
 Figure 7. Global Rheumatoid Arthritis Stem Cell Therapy Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Rheumatoid Arthritis Stem Cell Therapy Market Share by Application: 2024 VS 2031
 Figure 9. Hospitals Case Studies
 Figure 10. Ambulatory Surgical Centers Case Studies
 Figure 11. Specialty Clinics Case Studies
 Figure 12. Rheumatoid Arthritis Stem Cell Therapy Report Years Considered
 Figure 13. Global Rheumatoid Arthritis Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Rheumatoid Arthritis Stem Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Rheumatoid Arthritis Stem Cell Therapy Market Share by Region: 2024 VS 2031
 Figure 16. Global Rheumatoid Arthritis Stem Cell Therapy Market Share by Players in 2024
 Figure 17. Global Top Rheumatoid Arthritis Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatoid Arthritis Stem Cell Therapy as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Rheumatoid Arthritis Stem Cell Therapy Revenue in 2024
 Figure 19. North America Rheumatoid Arthritis Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Rheumatoid Arthritis Stem Cell Therapy Market Share by Country (2020-2031)
 Figure 21. United States Rheumatoid Arthritis Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Rheumatoid Arthritis Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Rheumatoid Arthritis Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Rheumatoid Arthritis Stem Cell Therapy Market Share by Country (2020-2031)
 Figure 25. Germany Rheumatoid Arthritis Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Rheumatoid Arthritis Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Rheumatoid Arthritis Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Rheumatoid Arthritis Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Rheumatoid Arthritis Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Rheumatoid Arthritis Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Market Share by Region (2020-2031)
 Figure 33. China Rheumatoid Arthritis Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Rheumatoid Arthritis Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Rheumatoid Arthritis Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Rheumatoid Arthritis Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Rheumatoid Arthritis Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Rheumatoid Arthritis Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Rheumatoid Arthritis Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Rheumatoid Arthritis Stem Cell Therapy Market Share by Country (2020-2031)
 Figure 41. Mexico Rheumatoid Arthritis Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Rheumatoid Arthritis Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Market Share by Country (2020-2031)
 Figure 45. Turkey Rheumatoid Arthritis Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Rheumatoid Arthritis Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Rheumatoid Arthritis Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Mesoblast Revenue Growth Rate in Rheumatoid Arthritis Stem Cell Therapy Business (2020-2025)
 Figure 49. Roslin Cells Revenue Growth Rate in Rheumatoid Arthritis Stem Cell Therapy Business (2020-2025)
 Figure 50. Regeneus Revenue Growth Rate in Rheumatoid Arthritis Stem Cell Therapy Business (2020-2025)
 Figure 51. ReNeuron Group Revenue Growth Rate in Rheumatoid Arthritis Stem Cell Therapy Business (2020-2025)
 Figure 52. International Stem Cell Corporation Revenue Growth Rate in Rheumatoid Arthritis Stem Cell Therapy Business (2020-2025)
 Figure 53. Takeda Revenue Growth Rate in Rheumatoid Arthritis Stem Cell Therapy Business (2020-2025)
 Figure 54. Bottom-up and Top-down Approaches for This Report
 Figure 55. Data Triangulation
 Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

RELATED REPORTS

Global Osteoarthritis Pain Solution Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20Y6853
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Regenerative Therapies for Osteoarthritis Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36Y13907
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Rheumatoid Arthritis Diagnosis Tests Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19O6132
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Psoriatic Arthritis Therapeutics Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9A6304
Mon Sep 08 00:00:00 UTC 2025

Add to Cart